Since the majority of the network associators of POTEE are epigenetically activated in many cancers as they have been reported in the literature, it is quite natural for POTEE paralog to get over-expressed and epigenetically regulated in ovarian cancer too. This evidence concerns the gene POTEE and ovarian carcinoma.